Medicine safety depends on reports made after approval too
藥品核准後,安全監測仍需要通報
更新於: 2026年11月2日 上午01:12
Approval is an important stage in a medicine's life, but safety monitoring continues afterward. MedSafetyWeek, running from November 2 to 8, 2026, draws attention to the information patients and health professionals can contribute after medicines enter everyday use.
核准是藥品生命週期中的重要階段,但之後仍須監測安全。2026年11月2日至8日的MedSafetyWeek,聚焦藥品進入日常使用後,病人與醫療專業人員能提供的資訊。
WHO explains that clinical trials cannot identify every possible side effect. Monitoring continues throughout a medicine's life cycle, as people use it in circumstances that may differ from those represented in the original trials.
世衛組織說明,臨床試驗無法找出所有可能的副作用。藥品整個生命週期都須持續監測,因為實際使用情境可能與原始試驗涵蓋的情況不同。
A suspected reaction need not appear immediately. Some symptoms develop after longer use, a change in dose or the use of several medicines together. WHO lists examples including skin rashes, stomach problems and changes in sleep or mood.
疑似不良反應不一定立即出現。有些症狀會在使用較久、改變劑量或同時使用多種藥品後發生。世衛列出的例子包括皮疹、腸胃問題,以及睡眠或情緒改變。
The campaign encourages reporting through national systems even when the cause is uncertain. A report records a suspicion. Combined with other reports and scientific evidence, it can help reveal a potential safety concern requiring further investigation.
活動鼓勵民眾,即使不確定原因,也可透過各國系統通報。通報記錄的是懷疑;與其他通報及科學證據結合後,可能幫助發現需要進一步調查的安全疑慮。
New Zealand's regulator Medsafe offers a concrete example: people can submit suspected reactions through the CARM online form. It says anyone concerned about their health after a possible side effect should speak with a healthcare professional.
紐西蘭藥品監管機關Medsafe提供一個具體例子:民眾可透過CARM線上表單通報疑似反應。該機關表示,若疑似副作用讓人擔心自身健康,應與醫療專業人員討論。
The wider message is participation. Patients, caregivers and professionals each see different parts of medicine use. Their reports help monitoring systems build knowledge over time, adding information that was unavailable when a treatment first received approval.
更廣泛的訊息是參與。病人、照顧者與專業人員,分別看見藥品使用的不同面向。他們的通報協助監測系統逐步累積知識,補上治療首次獲准時尚未取得的資訊。
